Australia-China researchers eye Asian stroke drug for Alzheimer's disease

Collaborating researchers from Australia and China report that Radicut (edaravone), a drug marketed only in a few Asian countries for treating strokes, may also be useful in treating progressive mental deterioration caused by Alzheimer's disease.

The work led by Xin-Fu Zhou at the University of South Australia with researchers at the Third Military Medical University in China was conducted on a mouse carrying a model of the disease. Zhou said the drug alleviated the disease and improved learning and memory in the test.

The researchers suggested the drug suppresses the oxidative stress that is a main cause of deterioration of the brain.

- here's the story from Business Insider

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.